NEWU — Newtopia Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Newtopia, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.11 | 11.4 | 10.5 | 11.2 | 9.78 |
| Cost of Revenue | |||||
| Gross Profit | 1.97 | 5.5 | 5.07 | 6.03 | 5.28 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 13.5 | 18.3 | 17.6 | 18 | 14.7 |
| Operating Profit | -7.35 | -6.89 | -7.19 | -6.8 | -4.96 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.1 | -7.73 | -7.65 | -7.7 | -6.6 |
| Net Income After Taxes | -10.1 | -7.73 | -7.65 | -7.7 | -6.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10.1 | -7.73 | -7.65 | -7.7 | -6.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.1 | -7.73 | -7.65 | -7.7 | -6.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.116 | -0.115 | -0.077 | -0.065 | -0.029 |
| Dividends per Share |